These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19193434)

  • 1. Methylation status of RASSF1A in patients with chronic myeloid leukemia.
    Avramouli A; Tsochas S; Mandala E; Katodritou E; Ioannou M; Ritis K; Speletas M
    Leuk Res; 2009 Aug; 33(8):1130-2. PubMed ID: 19193434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
    Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
    Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
    Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.
    Pehlivan M; Sercan Z; Sercan HO
    Leuk Res; 2009 Aug; 33(8):1062-7. PubMed ID: 19118898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of methylation in CML.
    Rachmilewitz EA
    Przegl Lek; 2000; 57 Suppl 1():25-6. PubMed ID: 10822991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [P15(INK4B) gene methylation in malignant hematopoietic diseases].
    Wu Q; Guo X; Fan H; Zhou T; Tan G; Guo Q; Chen P; Zhang X; Luo G; Xu M
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):644-6. PubMed ID: 11877040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia.
    Qian J; Wang YL; Lin J; Yao DM; Xu WR; Wu CY
    Eur J Haematol; 2009 Feb; 82(2):119-23. PubMed ID: 19018866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
    Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
    Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of RASSF1a in uveal melanoma.
    Maat W; van der Velden PA; Out-Luiting C; Plug M; Dirks-Mulder A; Jager MJ; Gruis NA
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):486-90. PubMed ID: 17251440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women.
    Li Y; Wei Q; Cao F; Cao X
    Oncol Rep; 2008 May; 19(5):1149-53. PubMed ID: 18425370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of PLCD1 in chronic myeloid leukemia.
    Song JJ; Liu Q; Li Y; Yang ZS; Yang L; Xiang TX; Ren GS; Chen JB
    Int J Mol Med; 2012 Jul; 30(1):179-84. PubMed ID: 22576628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p210(Bcr-Abl) desensitizes Cdc42 GTPase signaling for SDF-1alpha-directed migration in chronic myeloid leukemia cells.
    Chang YC; Tien SC; Tien HF; Zhang H; Bokoch GM; Chang ZF
    Oncogene; 2009 Nov; 28(46):4105-15. PubMed ID: 19718053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of progression in chronic myeloid leukemia by altering DNA methylation with a pyridoxine analogue.
    Sastry PS
    Med Hypotheses; 1999 Dec; 53(6):488-9. PubMed ID: 10687889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiposity and age are statistically related to enhanced RASSF1A tumor suppressor gene promoter methylation in normal autopsy kidney tissue.
    Peters I; Vaske B; Albrecht K; Kuczyk MA; Jonas U; Serth J
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2526-32. PubMed ID: 18086755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Polymorphism analysis of 5' promotor region of BCR gene].
    Tian H; Zheng WY; Fu YG; Lin JH; Lu FJ; Zhou SY
    Ai Zheng; 2004 Jul; 23(7):812-5. PubMed ID: 15248918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional activation of Skp2 by BCR-ABL in K562 chronic myeloid leukemia cells.
    Chen JY; Wang MC; Hung WC
    Leuk Res; 2009 Nov; 33(11):1520-4. PubMed ID: 19329185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth.
    Agirre X; Jiménez-Velasco A; San José-Enériz E; Garate L; Bandrés E; Cordeu L; Aparicio O; Saez B; Navarro G; Vilas-Zornoza A; Pérez-Roger I; García-Foncillas J; Torres A; Heiniger A; Calasanz MJ; Fortes P; Román-Gómez J; Prósper F
    Mol Cancer Res; 2008 Dec; 6(12):1830-40. PubMed ID: 19074828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.